Agency Forms Undergoing Paperwork Reduction Act Review, 40362-40363 [2012-16643]
Download as PDF
<![CDATA[
40362
Federal Register / Vol. 77, No. 131 / Monday, July 9, 2012 / Notices
responding clinics and an increase in
the estimated number of responses per
respondent. In addition, this Revision
request describes implementation of a
brief, one-time optional feedback survey
at the end of the data submission for
each reporting year. The feedback
survey will elicit information about
ART reporting system usability as well
as respondents’ perspectives on the
usefulness of the information collection.
Information is collected electronically
through the National ART Surveillance
System (NASS), a web-based interface,
or by electronic submission of NASScompatible files. The NASS includes
information about all ART cycles
initiated by any of the ART programs
practicing in the United States and its
territories. The system also collects
information about the pregnancy
outcome of each cycle as well as a
number of data items deemed important
to explain variability in success rates
across ART programs and individuals.
Respondents are the 484 ART
programs in the United States.
Approximately 440 ART programs are
expected to report an average of 339
ART cycles each. The burden estimate
includes the time for collecting,
validating, and reporting the requested
information. Information is collected on
an annual schedule.
There are no costs to the respondents
other than their time. The total
estimated annualized burden hours are
96,960.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Form name
ART Programs ................................................
NASS ..............................................................
Feedback Survey ...........................................
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
the U.S. (OMB No. 0920–0338, exp. 9/
30/2012)—Extension—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
[FR Doc. 2012–16645 Filed 7–6–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-12–0338]
Agency Forms Undergoing Paperwork
Reduction Act Review
sroberts on DSK5SPTVN1PROD with NOTICES
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Annual Submission of the Ingredients
Added to, and the Quantity of Nicotine
Contained in, Smokeless Tobacco
Manufactured, Imported, or Packaged in
VerDate Mar<15>2010
16:20 Jul 06, 2012
Jkt 226001
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), Office on Smoking
and Health (OSH) has the primary
responsibility for the Department of
Health and Human Services (HHS)
smoking and health program. HHS’s
overall goal is to reduce death and
disability resulting from the use of
smokeless tobacco products and other
forms of tobacco use through programs
of information, education and research.
Since 1994, as required by the
Comprehensive Smokeless Tobacco
Education Act of 1986 (CSTHEA, 15
U.S.C. 4401 et seq., Pub. L. 99–252),
CDC has collected information about the
ingredients used in smokeless tobacco
products and their nicotine content.
Respondents are commercial smokeless
tobacco product manufacturers,
packagers, or importers (or their
designated representatives), who are
required by the CSTHEA to submit
ingredient reports to HHS on an annual
basis. The legislation also authorizes
HHS to undertake research, and to
report to Congress, as deemed
appropriate, about the health effects of
these ingredients.
Respondents are not required to
submit specific forms; however, they are
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
440
176
Number of
responses per
respondent
339
1
Average
burden per
response
(in hours)
39/60
2/60
required to meet reporting guidelines
and to submit the ingredient report by
chemical name and Chemical Abstract
Service (CAS) Registration Number,
consistent with accepted reporting
practices for other companies currently
required to report ingredients added to
other consumer products. Typically,
respondents submit a summary report to
CDC with the ingredient information for
multiple products, or a statement that
there are no changes to their previously
submitted ingredient report.
Ingredient reports for new products
are due at the time of first importation.
Thereafter, ingredient reports are due
annually on March 31. Information is
submitted to OSH by mailing a written
report on the respondent’s letterhead, by
CD, three-inch floppy disk, or thumb
drive. The information collection is
subject to strict confidentiality
provisions and electronic mail
submissions are not accepted. Upon
receipt and verification of the annual
nicotine and ingredient report, OSH
issues a Certificate of Compliance to the
respondent.
OMB approval is requested for three
years. There are no changes to
information collection procedures or the
estimated burden per response. Due to
an increase in the estimated number of
respondents (from 11 to 13), there is an
increase in the total estimated
annualized burden hours (from 18,843
to 22,269). There are no costs to
respondents other than their time.
E:\FR\FM\09JYN1.SGM
09JYN1
40363
Federal Register / Vol. 77, No. 131 / Monday, July 9, 2012 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses
per
respondent
Average
burden per
response
(in hours)
Smokeless Tobacco Manufacturers, Packagers, and Importers.
SLT Nicotine and Ingredient and Report .......
13
1
1,713
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–16643 Filed 7–6–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–12–12II]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Risk Factors for Invasive Methicillinresistant Staphylococcus aureus
(MRSA) among Patients Recently
Discharged from Acute Care Hospitals
through the Active Bacterial Core
Surveillance for Invasive MRSA
infections (ABCs MRSA)—NEW—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Essential steps in reducing the
occurrence of healthcare-associated
invasive MRSA infections are to
quantify the burden and to identify
modifiable risk factors associated with
invasive MRSA disease. The current
CDC’s ABCs MRSA surveillance has
been essential to quantify the burden of
invasive MRSA in the United States.
Through this surveillance CDC was able
to estimate that 94,360 invasive MRSA
infections associated with 18,650 deaths
occurred in the United States in 2005.
The majority of these invasive infections
(58%) had onset in the community or
within 3 days of hospital admission and
occurred among individuals with recent
healthcare exposures (healthcareassociated community-onset [HACO]).
More recent data from the CDC’s ABCs
MRSA system have shown that two
thirds of invasive healthcare-associated
community-onset MRSA infections
occur among persons who are
discharged from an acute care hospital
in the prior 3 months. Risk factors for
invasive MRSA infections postdischarge have not been well evaluated,
and effective prevention measures in
this population remain uncertain.
For this project, an estimated total of
450 patients (150 patients with HACO
MRSA infection post-acute care
discharge and 300 patients without
HACO MRSA infection) will be
contacted for the MRSA interview
annually. This estimate is based on the
Number of
respondents
Type of respondents
Form name
Hospital Patients .............................................
sroberts on DSK5SPTVN1PROD with NOTICES
numbers of MRSA cases reported by the
ABCs MRSA sites annually (https://
www.cdc.gov/abcs/reports-findings/
survreports/mrsa08.html ) who are 18
years of age or older, had onset of the
MRSA infection in the community or
within 3 days of hospital admission,
and history of hospitalization in the
prior 3 months. ABCs MRSA
surveillance case report forms will be
used to identify HACO MRSA cases to
be contacted for a telephone interview.
For each HACO MRSA case identified;
2 patients without HACO MRSA
infection (control-patients) matched on
age with MRSA case will be contacted
for a health interview. All 450 patients
(both cases and controls) will be
screened for eligibility and those
considered to be eligible will complete
the telephone interview. We anticipate
that 350 of the 450 patients screened
will complete the telephone interview
across all 6 participating ABCs MRSA
sites per year. We anticipate the
screening questions to take about 5
minutes and the telephone interview 20
minutes per respondent.
Preventing healthcare-associated
invasive MRSA infections is one of CDC
priorities. The goal of this project is to
assess risk factors for invasive
healthcare-associated MRSA infections,
which will inform the development of
targeted prevention measures. This
activity supports the HHS Action Plan
for elimination of healthcare-associated
infections.
There are no costs to respondents.
The total response burden for the study
is estimated as 155 hours.
Screening Form ..............................................
Telephone interview .......................................
VerDate Mar<15>2010
16:20 Jul 06, 2012
Jkt 226001
PO 00000
Frm 00044
Fmt 4703
Sfmt 9990
E:\FR\FM\09JYN1.SGM
450
350
09JYN1
Number of
responses
per
respondent
Average
burden per
response
(in hours)
1
1
5/60
20/60
]]>Agencies
[Federal Register Volume 77, Number 131 (Monday, July 9, 2012)]
[Notices]
[Pages 40362-40363]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-16643]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-12-0338]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-7570 or send an email to
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Annual Submission of the Ingredients Added to, and the Quantity of
Nicotine Contained in, Smokeless Tobacco Manufactured, Imported, or
Packaged in the U.S. (OMB No. 0920-0338, exp. 9/30/2012)--Extension--
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC), Office on
Smoking and Health (OSH) has the primary responsibility for the
Department of Health and Human Services (HHS) smoking and health
program. HHS's overall goal is to reduce death and disability resulting
from the use of smokeless tobacco products and other forms of tobacco
use through programs of information, education and research.
Since 1994, as required by the Comprehensive Smokeless Tobacco
Education Act of 1986 (CSTHEA, 15 U.S.C. 4401 et seq., Pub. L. 99-252),
CDC has collected information about the ingredients used in smokeless
tobacco products and their nicotine content. Respondents are commercial
smokeless tobacco product manufacturers, packagers, or importers (or
their designated representatives), who are required by the CSTHEA to
submit ingredient reports to HHS on an annual basis. The legislation
also authorizes HHS to undertake research, and to report to Congress,
as deemed appropriate, about the health effects of these ingredients.
Respondents are not required to submit specific forms; however,
they are required to meet reporting guidelines and to submit the
ingredient report by chemical name and Chemical Abstract Service (CAS)
Registration Number, consistent with accepted reporting practices for
other companies currently required to report ingredients added to other
consumer products. Typically, respondents submit a summary report to
CDC with the ingredient information for multiple products, or a
statement that there are no changes to their previously submitted
ingredient report.
Ingredient reports for new products are due at the time of first
importation. Thereafter, ingredient reports are due annually on March
31. Information is submitted to OSH by mailing a written report on the
respondent's letterhead, by CD, three-inch floppy disk, or thumb drive.
The information collection is subject to strict confidentiality
provisions and electronic mail submissions are not accepted. Upon
receipt and verification of the annual nicotine and ingredient report,
OSH issues a Certificate of Compliance to the respondent.
OMB approval is requested for three years. There are no changes to
information collection procedures or the estimated burden per response.
Due to an increase in the estimated number of respondents (from 11 to
13), there is an increase in the total estimated annualized burden
hours (from 18,843 to 22,269). There are no costs to respondents other
than their time.
[[Page 40363]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Smokeless Tobacco Manufacturers, SLT Nicotine and 13 1 1,713
Packagers, and Importers. Ingredient and Report.
----------------------------------------------------------------------------------------------------------------
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012-16643 Filed 7-6-12; 8:45 am]
BILLING CODE 4163-18-P
